Edition:
United Kingdom

People: Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

22.30USD
13 Sep 2019
Change (% chg)

-- (--)
Prev Close
$22.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
534,041
52-wk High
$45.12
52-wk Low
$19.37

Hopkinson, Craig 

Dr. Craig C. Hopkinson, M.D., is Senior Vice President - Medicines Development and Medical Affairs, Chief Medical Officer of the Company, since February 1, 2018. Prior to assuming his current positions, Dr. Hopkinson was our Chief Medical Officer, and Senior Vice President of Clinical Development and Medical Affairs from May 2017 to February 2018. Prior to joining the Company, Dr. Hopkinson served as Senior Vice President and Head of Global Affairs at Vertex Pharmaceuticals from July 2014 until May 2017. Prior to that, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President Eisai Value Maximization Systems from January 2013 to July 2014 and President and Chief Medical Officer from October 2011 to December 2012. Dr. Hopkinson has extensive experience in research and development, medical affairs, and with the U.S. Food and Drug Administration (the “FDA”). Dr. Hopkinson is also a member of the South African Association of Pharmaceutical Physicians.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

9,380,490

James Frates

2,828,540

Elliot Ehrich

3,547,020

Iain Brown

--

David Gaffin

--

Michael Landine

--
As Of  31 Dec 2017